Pregnancy in Vascular EDS

Pregnancy Considerations

Pregnancy presents a particular risk in female patients with vascular Ehlers-Danlos syndrome. It is associated with an increased risk of pregnancy-related complications, directly related to the tissue fragility which is characteristic of the disease.

What advice is given with vascular EDS when considering a pregnancy?

Before planning a family it is important to discuss the implications of pregnancy with your family doctor (GP) and your geneticist or genetic counsellor who will discuss the options available to you.

It is also useful to speak to an obstetrician (a doctor who specialises in the care of pregnant women), who has experience with vascular EDS, before planning a pregnancy. We would recommend that the obstetrician contacts the EDS National Diagnostic Service for advice and guidance, adopting an MDT (Multi-Disciplinary Team) approach to planning your pregnancy.

Is there particular advice for women with vascular EDS who are pregnant?

Any pregnancy puts the cardiovascular system (heart and blood vessels) under exceptional pressure. There are additional risks women with vascular EDS in pregnancy, due to blood vessel fragility. It is essential that the obstetrician and midwives are aware of the diagnosis of vascular EDS as soon as the pregnancy is confirmed.

We recommend starting maternity leave and resting from 30 weeks of pregnancy, or possibly earlier if recommended by the obstetrician. As pregnancy progresses pregnant women with vascular EDS have a higher chance of blood vessel or uterine rupture. The timing of delivery of the baby will be decided by the obstetrician.

A planned Caesarean delivery, in a hospital with access to specialist vascular surgery may be suggested. The baby may be born prematurely because the cervix and membranes surrounding the baby can be weak or fragile. There is also evidence that women with vascular EDS have a higher risk of tears (lacerations) during delivery.

We know that women with vascular EDS have an increased chance of dying during pregnancy, or in the weeks following birth. It is difficult to estimate the chance of this happening, but studies suggest it may be as high as 10% of pregnancies. Many women still choose to become pregnant, while others may choose surrogacy or adoption.

Consideration should also be given that there is a 50% (1 in 2) chance of a child inheriting the altered copy of the gene and having vascular EDS. Equally, there is a 50% (1 in 2) chance of a child getting the unaltered copy of the gene and not inheriting the condition.

Source: EDS National Diagnostic Service.

Pregnancy

What is recommended

Discuss any planned pregnancy with the medical and obstetrics referral team prior to conception.
The occurrence of arterial or digestive system incidents may contraindicate a pregnancy.
Discuss and suggest the possibility of performing prenatal diagnosis.
Perform a complete arterial lesion assessment before or in early pregnancy.
Arrange for increased monitoring of the uterine cervix, especially from the 28th week onwards.
Maintain treatment with Celiprolol (if applicable), or introduce it if the pregnancy started without treatment.

What you should not do

Interrupt treatment with beta-blockers during pregnancy and the peripartum period.

Delivery

There are no formal recommendations regarding the best method of delivery for patients with vascular Ehlers-Danlos syndrome. A caesarean section between 35 and 37 weeks of gestation is the approach adopted by the reference centre for rare vascular diseases, especially for primiparous patients with a known diagnosis.

What is recommended

Schedule the delivery due to the elevated risk of maternal complications.
Always recommend carrying out a caesarean section between 35 and 37 weeks of gestation.
Plan for the birth to take place in a level 3 maternity unit.

What you should not do

Delivery at home or in a level 1-2 maternity unit.
Vaginal delivery without prior multidisciplinary consultation.

Breastfeeding

Vascular Ehlers-Danlos syndrome in itself is not a contraindication to breastfeeding. Nonetheless, the beta-blocker treatment prescribed to prevent the vascular complications of the disease in the mother is not generally recommended during breastfeeding as it is transmitted to the newborn through breast milk.

What is recommended

Discuss breastfeeding on a case-by-case basis with the attending obstetric and paediatric teams.

What you should not do

Interrupt the mother’s beta-blocker treatment with Celiprolol in order to allow for breastfeeding.
Consider breastfeeding when the newborn has displayed side-effects of betablocker use (including bradycardia, respiratory distress and/or hypoglycemia).
Consider breastfeeding when maternal complications, related to vascular Ehlers-Danlos syndrome, have been reported in the peripartum period.

Source: VASCERN European Reference Network.

Is IVF safe in vEDS patients?

Pre-implantation Genetic Diagnosis (PGD)

For couples at risk of having a child with a serious genetic condition, pre-implantation genetic diagnosis (PGD) may be an option.

PGD involves using in-vitro fertilisation (IVF), where eggs are removed from a woman's ovaries before being fertilised with sperm in a laboratory. After a few days, the resulting embryos can be tested for a particular genetic mutation and a maximum of two unaffected embryos are transferred into the uterus.

PGD has the advantage of avoiding the termination of foetuses affected by serious conditions, but it also has a number of drawbacks. These include the modest success rate of achieving a pregnancy after IVF, and the substantial financial and emotional costs of the combined IVF and PGD process – PGD isn't always available on the NHS. Click here for more information on PGD carried out at Guy's and St Thomas' NHS Foundation Trust.

Page last reviewed: July 2023